Back to glossary
Biomarkers

Neutrophil-lymphocyte ratio (NLR)

DENeutrophilen-Lymphozyten-Quotient (NLR)

Reviewed by

The neutrophil-lymphocyte ratio (NLR) is derived from a standard complete blood count as the absolute neutrophil count divided by the absolute lymphocyte count, with a typical reference range of approximately 1–3 in healthy adults. It reflects the balance between the innate (neutrophil-driven) and adaptive (lymphocyte-driven) arms of the immune system: higher NLR indicates relative dominance of innate proinflammatory activity and/or suppression of adaptive immunity. Elevated NLR is associated with worse prognosis in a broad range of cancers, higher incidence of cardiovascular events, chronic kidney disease, and metabolic syndrome, and independently predicts all-cause mortality in large population cohorts. Physiologically, NLR rises sharply during acute stress, infection, or corticosteroid use, but persistently elevated values at rest are a marker of chronic inflammaging and immune senescence, making it a useful, cost-free index derived from routine laboratory data.

Sources

  1. Forget P, Khalifa C, Defour JP, Latinne D, Van Pel MC, De Kock M. (2017). The neutrophil-to-lymphocyte ratio: a narrative review. *Immunology Letters*doi:10.1016/j.imlet.2016.11.006
  2. Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al.. (2014). Elevated preoperative neutrophil to lymphocyte ratio as a predictor of postoperative complications and overall survival in all cancer types: a systematic review and meta-analysis. *Journal of the National Cancer Institute*doi:10.1093/jnci/dju124